Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gene Expression Profiling | 13 | 2016 | 9438 | 0.480 |
Why?
|
Burns | 7 | 2014 | 1815 | 0.440 |
Why?
|
RNA Splice Sites | 1 | 2012 | 209 | 0.380 |
Why?
|
Proteome | 6 | 2014 | 1799 | 0.380 |
Why?
|
Alternative Splicing | 3 | 2012 | 1117 | 0.370 |
Why?
|
Gene Expression Regulation | 8 | 2016 | 12072 | 0.360 |
Why?
|
Leukocytes | 5 | 2011 | 2043 | 0.350 |
Why?
|
Computational Biology | 6 | 2016 | 3521 | 0.330 |
Why?
|
Proteomics | 6 | 2014 | 3638 | 0.330 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2012 | 3920 | 0.300 |
Why?
|
Blood Proteins | 6 | 2010 | 1124 | 0.260 |
Why?
|
Sequence Analysis, RNA | 2 | 2012 | 2012 | 0.250 |
Why?
|
Software | 5 | 2016 | 4443 | 0.230 |
Why?
|
Genome, Human | 3 | 2011 | 4420 | 0.190 |
Why?
|
Pseudomonas Infections | 4 | 2011 | 613 | 0.160 |
Why?
|
Transcription, Genetic | 2 | 2011 | 7722 | 0.160 |
Why?
|
Databases, Genetic | 3 | 2014 | 1783 | 0.150 |
Why?
|
Exons | 3 | 2012 | 2437 | 0.150 |
Why?
|
Mass Spectrometry | 5 | 2014 | 2203 | 0.150 |
Why?
|
Databases, Nucleic Acid | 1 | 2016 | 211 | 0.130 |
Why?
|
Chromatography, Liquid | 4 | 2010 | 976 | 0.130 |
Why?
|
Oxygen Isotopes | 3 | 2010 | 44 | 0.120 |
Why?
|
Inflammation | 7 | 2016 | 10638 | 0.120 |
Why?
|
Trauma Severity Indices | 2 | 2014 | 481 | 0.110 |
Why?
|
Multiple Organ Failure | 2 | 2014 | 390 | 0.110 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12261 | 0.110 |
Why?
|
Endotoxins | 2 | 2011 | 527 | 0.100 |
Why?
|
Reference Standards | 2 | 2012 | 1025 | 0.090 |
Why?
|
Chromatography, Ion Exchange | 3 | 2005 | 305 | 0.090 |
Why?
|
Glutathione Transferase | 1 | 2011 | 595 | 0.090 |
Why?
|
Wound Infection | 1 | 2011 | 242 | 0.090 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 528 | 0.090 |
Why?
|
Lipopolysaccharides | 3 | 2005 | 2216 | 0.080 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2011 | 659 | 0.080 |
Why?
|
Isotope Labeling | 1 | 2010 | 406 | 0.080 |
Why?
|
RNA | 3 | 2010 | 2749 | 0.080 |
Why?
|
Wounds and Injuries | 5 | 2010 | 2400 | 0.080 |
Why?
|
Benchmarking | 1 | 2014 | 1042 | 0.080 |
Why?
|
Muscles | 1 | 2012 | 1614 | 0.070 |
Why?
|
Neoplasm, Residual | 1 | 2011 | 973 | 0.070 |
Why?
|
Genes, Regulator | 1 | 2007 | 378 | 0.070 |
Why?
|
Adaptive Immunity | 1 | 2011 | 713 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 2 | 2005 | 1219 | 0.070 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 323 | 0.070 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 276 | 0.070 |
Why?
|
Genomics | 3 | 2016 | 5720 | 0.060 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 944 | 0.060 |
Why?
|
Microfluidics | 1 | 2010 | 662 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 2011 | 4931 | 0.060 |
Why?
|
Peptides | 2 | 2014 | 4409 | 0.060 |
Why?
|
Immunity, Innate | 3 | 2011 | 2958 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3597 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4776 | 0.060 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 503 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2011 | 1401 | 0.060 |
Why?
|
Cell Separation | 1 | 2008 | 1751 | 0.050 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2005 | 362 | 0.050 |
Why?
|
Critical Illness | 2 | 2014 | 2670 | 0.050 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2008 | 828 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2016 | 18029 | 0.050 |
Why?
|
Critical Care | 1 | 2014 | 2647 | 0.050 |
Why?
|
Drosophila melanogaster | 3 | 2007 | 1708 | 0.050 |
Why?
|
Computer Simulation | 1 | 2014 | 6196 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1596 | 0.050 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4740 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 1677 | 0.040 |
Why?
|
Proteins | 1 | 2014 | 6103 | 0.040 |
Why?
|
Gene Regulatory Networks | 1 | 2007 | 1708 | 0.040 |
Why?
|
Trypsin | 2 | 2010 | 511 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2012 | 13033 | 0.040 |
Why?
|
Humans | 26 | 2016 | 744343 | 0.040 |
Why?
|
Neutrophils | 1 | 2010 | 3719 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2010 | 5097 | 0.040 |
Why?
|
Drosophila Proteins | 2 | 2005 | 1703 | 0.040 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 2866 | 0.040 |
Why?
|
Monocytes | 1 | 2006 | 2596 | 0.040 |
Why?
|
Reproducibility of Results | 7 | 2011 | 19905 | 0.040 |
Why?
|
Liver | 1 | 2012 | 7474 | 0.030 |
Why?
|
Cluster Analysis | 3 | 2010 | 2715 | 0.030 |
Why?
|
Hemorrhage | 1 | 2007 | 3461 | 0.030 |
Why?
|
Algorithms | 2 | 2012 | 13881 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5442 | 0.030 |
Why?
|
Oxygen | 1 | 2005 | 4189 | 0.030 |
Why?
|
Species Specificity | 1 | 2016 | 2478 | 0.030 |
Why?
|
Gene Expression | 1 | 2005 | 7799 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2010 | 6365 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 2011 | 1782 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 386 | 0.020 |
Why?
|
Immunosorbent Techniques | 1 | 2010 | 184 | 0.020 |
Why?
|
Aldehydes | 1 | 2011 | 167 | 0.020 |
Why?
|
Toll-Like Receptors | 2 | 2005 | 592 | 0.020 |
Why?
|
Biotinylation | 1 | 2010 | 179 | 0.020 |
Why?
|
Genes, Mitochondrial | 1 | 2010 | 61 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6171 | 0.020 |
Why?
|
Specimen Handling | 2 | 2005 | 694 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 2010 | 291 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 262 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2010 | 434 | 0.020 |
Why?
|
Isotopes | 1 | 2009 | 124 | 0.020 |
Why?
|
Adult | 7 | 2014 | 214055 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2006 | 10180 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2011 | 572 | 0.020 |
Why?
|
Troponin C | 1 | 2007 | 25 | 0.020 |
Why?
|
Time Factors | 5 | 2010 | 40075 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2902 | 0.020 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2007 | 148 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2011 | 453 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2892 | 0.020 |
Why?
|
Chemical Fractionation | 1 | 2006 | 65 | 0.020 |
Why?
|
Animals | 7 | 2016 | 168757 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 17446 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 868 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 2008 | 0.020 |
Why?
|
Kidney Cortex | 1 | 2005 | 186 | 0.020 |
Why?
|
Male | 7 | 2014 | 350118 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2006 | 261 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2011 | 1530 | 0.020 |
Why?
|
Electrophoresis, Capillary | 1 | 2005 | 64 | 0.020 |
Why?
|
Female | 7 | 2014 | 380194 | 0.020 |
Why?
|
Peptide Mapping | 1 | 2005 | 263 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2011 | 13989 | 0.020 |
Why?
|
Suppression, Genetic | 1 | 2005 | 196 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2010 | 1602 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 3002 | 0.010 |
Why?
|
Fourier Analysis | 1 | 2005 | 447 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 2007 | 662 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 2004 | 246 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2011 | 21746 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14722 | 0.010 |
Why?
|
Enterotoxins | 1 | 2004 | 368 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2005 | 940 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2007 | 3701 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4982 | 0.010 |
Why?
|
Spleen | 1 | 2007 | 2362 | 0.010 |
Why?
|
Mice | 3 | 2016 | 81183 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5974 | 0.010 |
Why?
|
Virulence | 1 | 2005 | 1333 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6309 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3582 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2006 | 2971 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2014 | 5317 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12797 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2716 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4026 | 0.010 |
Why?
|
Virulence Factors | 1 | 2003 | 509 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 2004 | 1171 | 0.010 |
Why?
|
Middle Aged | 5 | 2014 | 213383 | 0.010 |
Why?
|
Prospective Studies | 2 | 2014 | 53288 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14557 | 0.010 |
Why?
|
Adolescent | 3 | 2014 | 85781 | 0.010 |
Why?
|
DNA | 1 | 2010 | 7301 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 20947 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4217 | 0.010 |
Why?
|
Models, Statistical | 1 | 2010 | 5102 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7149 | 0.010 |
Why?
|
Signal Transduction | 2 | 2010 | 23403 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18370 | 0.010 |
Why?
|
Patient Selection | 1 | 2005 | 4215 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39050 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13815 | 0.010 |
Why?
|
Cytokines | 1 | 2006 | 7322 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 18111 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12951 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29063 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 25043 | 0.010 |
Why?
|
Research Design | 1 | 2004 | 5987 | 0.010 |
Why?
|
Infant | 1 | 2010 | 35136 | 0.000 |
Why?
|
Young Adult | 1 | 2014 | 56430 | 0.000 |
Why?
|
Child, Preschool | 1 | 2010 | 41006 | 0.000 |
Why?
|
Aging | 1 | 2005 | 8664 | 0.000 |
Why?
|
United States | 1 | 2014 | 69872 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2014 | 77449 | 0.000 |
Why?
|
Aged | 2 | 2005 | 163280 | 0.000 |
Why?
|
Child | 1 | 2010 | 77709 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2005 | 57776 | 0.000 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_